Please login to the form below
Pharmaceutical Market Europe (PME)
PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
Novartis forges AI alliance with Oxford University
Part of Novartis drive to become 'data-driven' pharma company
FDA adcomm split on Sanofi’s type 1 diabetes drug
Concerns rose after Zynquista-treated patients showed an eight-fold increase in DKA
Evenity back on track with FDA panel blessing in osteoporosis
US drugs regulator first rejected the drug due to cardiovascular concerns
NICE gives Lilly’s Verzenios chance to compete with rivals
Breast cancer drug also being appraised in novel combination
Articles
-
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?Healthcare leaders in the European Union should begin preparing for a breakthrough now
-
The UK’s new five-year pricing agreementPharma has agreed to capped growth again - in exchange for uptake promises
-
Launch excellence: beyond the six-month mantraWhile the first six months are important, the prior 36 months are even more so.
-
Escaping the spin cycle of sub-optimal launch -
Relearning launch: Four key dynamics for pharma launches in 2019Syneos Health examines some of the key trends shaping industry launches in 2019 and beyond
Pharmaceutical Market Europe - January 2019
Just a few years into the New Year, the $74bn acquisition of Celgene by BMS has woken us all up from our post-festive slump with a bang. The merger is the fourth biggest ever, and could spark more multi-billion dollar M&A deals over the next 12 months.
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Editor - Iona Everson
Have your say...
Subscribe
'Nothing about us without us'
Why patient engagement is essential throughout the entire product life cycle
Featured jobs
-
Senior Account Manager
-
Competitive Salary Offered
-
Account Director, Medical Education
-
Salary TBC
- Global Business Development Director – Health Education
-
excellent commission
-
Business Director
-
Competitive Salary Offered
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Associate Director
-
£75, 000-90, 000
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Medical Writer
-
Salary TBC
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Account Director
-
Competitive Salary Offered
-
Senior Medical Writer
-
Salary TBC
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Account Manager / Account Director
-
Competative
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Novartis forges AI alliance with Oxford University
- FDA adcomm split on Sanofi’s type 1 diabetes drug
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
PMHub
Hive
We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
